So far for holders directors have let the share price slide so far with no concrete news that anything that is released may well be treated with scepticism.
As I've said before I do think cardiocel would be complimentary to a bigger players portfolio of products but at what price .
I have always had concerns about the focus on US domicile for management .
" hey guys - we got this little ol Aussie company with some good stuff - we kinda control it but if you look after us you can have it "
Of course this is only my waffle and very likely to be absolute crap
Answers from WP - a good read, page-304
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |